Compulsory treatment with clozapine: A retrospective long-term cohort study

被引:15
作者
Schulte, Peter F. J. [1 ]
Stienen, Juan J. [2 ]
Bogers, Jan [3 ]
Cohen, Dan [1 ,4 ]
van Dijk, Daniel [5 ]
Lionarons, Wendell H. [6 ]
Sanders, Sophia S. [7 ]
Heck, Adolph H. [8 ,9 ]
机构
[1] Mental Hlth Serv N Holland N, Dept De Dijk, NL-1851 NG Heiloo, Netherlands
[2] Red Cross Hosp, Dept Psychiat, Beverwijk, Netherlands
[3] Mental Hlth Serv Rivierduinen, Dept Haagstreek, Leidschendam, Netherlands
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Epidemiol, Groningen, Netherlands
[5] Psychiat Hosp Dijk & Duin, Castricum, Netherlands
[6] Altrecht Mental Hlth, Utrecht, Netherlands
[7] Mental Hlth Serv Buiten Amstel De Geestgronden, Dept Amstelveen, Amstelveen, Netherlands
[8] Psychiat Hosp Symfora Grp, Amersfoort, Netherlands
[9] Forens Psychiat Hosp Veldzicht, Balkbrug, Netherlands
关键词
clozapine; schizophrenia; treatment refusal; treatment outcome;
D O I
10.1016/j.ijlp.2007.09.003
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
Background: Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. We know little about the effects of compulsory treatment in patients unwilling to accept the necessary treatment. Aims: To assess the effectiveness, tolerability and safety of compulsory treatment with clozapine (CTC). Method: A cohort of 17 consecutive patients given compulsory treatment with clozapine were rated retrospectively by their treating psychiatrists on the basis of their case notes. Results: CGI-S decreased significantly over tithe until last observation after a mean of more than 15 months. No patient deteriorated as measured by CGI-1. At last observation as many as ten of the 11 patients still on clozapine were classified as much to very much improved. The degree of custodial restriction at last observation showed improvement in 11 patients and no change in six. No serious adverse events were observed. Conclusion: A trial of compulsory treatment with clozapine showed this treatment to be feasible, effective, safe and well tolerated. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:539 / 545
页数:7
相关论文
共 25 条
[1]  
ADAMS NHS, 1991, AUST NZ J PSYCHIAT, V25, P231, DOI 10.3109/00048679109077739
[2]   CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES [J].
ALVIR, JMJ ;
LIEBERMAN, JA ;
SAFFERMAN, AZ ;
SCHWIMMER, JL ;
SCHAAF, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) :162-167
[3]  
[Anonymous], AM J PSYCHIAT S
[4]  
[Anonymous], REV CONT PHARMACOTHE
[5]   THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE [J].
BUCHANAN, RW ;
HOLSTEIN, C ;
BREIER, A .
BIOLOGICAL PSYCHIATRY, 1994, 36 (11) :717-725
[6]   Modelling the impact of clozapine on suicide in patients with treatment-resistant schizophrenia in the UK [J].
Duggan, A ;
Warner, J ;
Knapp, M ;
Kerwin, R .
BRITISH JOURNAL OF PSYCHIATRY, 2003, 182 :505-508
[7]  
FINZEN A, 1993, HILFE WIDER WILLEN B
[8]  
Greenberg WM, 1996, B AM ACAD PSYCH LAW, V24, P513
[9]   MOCLOBEMIDE VERSUS CLOMIPRAMINE IN ENDOGENOUS-DEPRESSION - A DOUBLE-BLIND RANDOMIZED CLINICAL-TRIAL [J].
GUELFI, JD ;
PAYAN, C ;
FERMANIAN, J ;
PEDARRIOSSE, AM ;
MANFREDI, R .
BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 :519-524
[10]  
Guy W, 1976, PUBLICATION ADM, V76-338, P218